Beijing Tiantan Biological Products Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Beijing Tiantan Biological Products has a total shareholder equity of CN¥13.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥15.6B and CN¥1.7B respectively. Beijing Tiantan Biological Products's EBIT is CN¥2.0B making its interest coverage ratio -22. It has cash and short-term investments of CN¥4.8B.
Anahtar bilgiler
0%
Borç/özkaynak oranı
CN¥0
Borç
| Faiz karşılama oranı | -22x |
| Nakit | CN¥4.80b |
| Eşitlik | CN¥13.85b |
| Toplam yükümlülükler | CN¥1.71b |
| Toplam varlıklar | CN¥15.55b |
Son finansal sağlık güncellemeleri
Recent updates
Beijing Tiantan Biological Products Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Oct 29
Beijing Tiantan Biological Products (SHSE:600161) Ticks All The Boxes When It Comes To Earnings Growth
Oct 27Calculating The Fair Value Of Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161)
Oct 08Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Shares May Have Run Too Fast Too Soon
Sep 19Does Beijing Tiantan Biological Products (SHSE:600161) Deserve A Spot On Your Watchlist?
Jul 23Is Beijing Tiantan Biological Products Co., Ltd. (SHSE:600161) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 09Beijing Tiantan Biological Products Co., Ltd.'s (SHSE:600161) Price Is Out Of Tune With Earnings
May 22We Think Beijing Tiantan Biological Products (SHSE:600161) Can Stay On Top Of Its Debt
Mar 16Do Beijing Tiantan Biological Products' (SHSE:600161) Earnings Warrant Your Attention?
Mar 01Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 600161's short term assets (CN¥8.5B) exceed its short term liabilities (CN¥1.6B).
Uzun Vadeli Yükümlülükler: 600161's short term assets (CN¥8.5B) exceed its long term liabilities (CN¥153.6M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 600161 is debt free.
Borcun Azaltılması: 600161 has no debt compared to 5 years ago when its debt to equity ratio was 8%.
Borç Kapsamı: 600161 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 600161 has no debt, therefore coverage of interest payments is not a concern.